The company intends to sell up to $75 million of its common stock for working capital and other purposes.
The deal adds germline mutation information to the tumor sequencing, proteomic, and phosphoproteomic data Perthera currently uses to guide patient therapy.
The company has also developed software that will enable automated melt curve analysis on Cepheid's existing GeneXpert platforms.
The company, which is collaborating with Myeloma Crowd, will use the newly-licensed minicircle DNA technology to develop therapies for multiple myeloma.
The Screen Project is a new initiative started by researchers in the WCH Familial Breast Cancer Research Unit to test men and women for BRCA1 and BRCA2.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.